Sciety invests in cancer diagnostics of the future with Industrifonden
Sciety invests SEK 35 million in Elypta, a diagnostic company developing a new technology for early cancer diagnosis. The Sciety investment syndicate together with the Swedish venture capital fund Industrifonden, Chalmers Ventures and several of the company’s existing owners participated in this investment round. The new capital amounting to SEK 64.8 million will be dedicated to a study which is expected to be sufficient for a market approval in both Europe and the USA.Elypta was founded at Chalmers to develop a technology for early detection of cancer. The technology is based on measuring